Akebia Therapeutics' Vafseo expansion may boost future growth despite Auryxia's exclusivity loss. Read why AKBA stock is ...

Dave Ramsey, the personal finance bestselling author and radio host, warns Americans about the challenges of saving for ...

The bullish arguments hold water, to be sure. Chief among them is the sheer cost of a new car. Data from Kelley Blue Book ...

Micron is heading into its quarterly report with a major catalyst in the form of artificial intelligence (AI) on its side, ...

Nvidia (NASDAQ: NVDA) is the most valuable company in the world as of this writing, with a market cap of $3.4 trillion, and ...

Globally, the number of so-called “millionaires next door” — individuals worth between $1 million and $5 million — grew by ...

Discover why Taiwan Semiconductor (TSMC) stock could be the smartest AI investment of 2025, and the surprising risks that ...

The stock market is often driven by emotion. Information breaks about a company struggling to reach profitability or wider ...

RxSight offers strong growth potential in cataract treatment, with scalable tech, a large market, and attractive valuation.

Things have been good for stocks over the last two months. Maybe too good, according to a new report from Bank of America.

Stocks rose on Wall Street Friday following a better-than-expected report on the U.S. job market. The S&P 500 index rose 1.2% ...

The typical compensation package for chief executives who run companies in the S&P 500 jumped nearly 10% in 2024 as ...